In a remarkable financial turn, Torrent Pharmaceuticals has disclosed a staggering 30% rise in after-tax profit for the September quarter, reaching ₹591 crore. This impressive growth is attributed to thriving sales in various markets, which escalated their total revenue to ₹3,302 crore.
AI stocks: Midterm elections could threaten AI trade as data center backlash grows
Public opposition to US data centers and the November midterm elections could reshape AI infrastructure investment. Increased regulatory scrutiny, rising electricity costs and construction delays